Astragaloside A (Astragaloside IV), Ca2+ signaling modulator (ab143183)

Overview

  • Product name
    Astragaloside A (Astragaloside IV), Ca2+ signaling modulator
  • Description
    Ca2+ signaling modulator, antioxidant agent
  • Biological description
    Ca2+ signaling modulator, antioxidant agent. Reduces sarcoplasmic Ca2+ uptake and Ca2+-ATPase activity. Enhances the action of ATP-sensitive K+ channels. Increases cytosol SOD concentration. Shows anti-ischemic effects in vivo. Orally active.
  • Purity
    > 98%

Properties

References

This product has been referenced in:
  • Ren S  et al. Pharmacological effects of Astragaloside IV: a literature review. J Tradit Chin Med 33:413-6 (2013). Read more (PubMed: 24024343) »
  • Liu G  et al. Astragalus injection protects cerebral ischemic injury by inhibiting neuronal apoptosis and the expression of JNK3 after cerebral ischemia reperfusion in rats. Behav Brain Funct 9:36 (2013). Read more (PubMed: 24083559) »
  • Han XH  et al. Astragaloside IV regulates expression of ATP-sensitive potassium channel subunits after ischemia-reperfusion in rat ventricular cardiomyocytes. J Tradit Chin Med 31:321-6 (2011). Read more (PubMed: 22462239) »

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab143183.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"

Sign up